Abemaciclib induces apoptosis in cardiomyocytes by activating the Hippo signaling pathway

Yajie Zhou1,2, Yanfei Li3, Junwei Shen4

  • 1Clinical Medical College, Guizhou Medical University, Guiyang 550004, China.

Insights

Abemaciclib, a new breast cancer drug, may harm heart cells by triggering apoptosis and inhibiting proliferation via the Hippo pathway. This research reveals the molecular mechanism behind potential cardiac side effects.

Area of Science:

  • Cardiology
  • Oncology
  • Molecular Biology

Background:

  • Abemaciclib is an FDA-approved cyclin-dependent kinase 4/6 inhibitor for advanced breast cancer.
  • Potential adverse effects on cardiomyocytes are not well understood.

Purpose of the Study:

  • To investigate the effects of abemaciclib on human cardiomyocyte cells.
  • To elucidate the molecular mechanisms underlying abemaciclib-induced cardiotoxicity.

Main Methods:

  • Cell counting kit-8 assay
  • Western blot analysis
  • Flow cytometry
  • Immunostaining
  • Quantitative polymerase chain reaction (qPCR) on AC16 human cardiomyocyte cells.

Main Results:

  • Abemaciclib significantly inhibited viability and proliferation of AC16 cells.
  • Abemaciclib induced apoptosis in AC16 cells.
  • Activation of the Hippo signaling pathway was observed.

Conclusions:

  • Abemaciclib induces cardiomyocyte apoptosis and inhibits proliferation through Hippo pathway activation.
  • This study provides insights into the molecular basis of abemaciclib's cardiac side effects.
  • Identifies potential therapeutic targets for managing cardiotoxicity.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
9.5K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
13.5K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
7.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K